SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001190725-16-000403
Filing Date
2016-05-19
Accepted
2016-05-19 18:12:02
Documents
1
Period of Report
2016-05-18

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 3832
  Complete submission text file 0001190725-16-000403.txt   5254
Mailing Address C/O INTRABIOTICS PHARMACEUTICALS INC 1245 TERRA BELLA AVENUE MOUNTAIN VIEW CA 94043
Business Address
FUCHS HENRY J (Reporting) CIK: 0001197355 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35921 | Film No.: 161664284

Mailing Address 9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 858-332-3410
Mirati Therapeutics, Inc. (Issuer) CIK: 0001576263 (see all company filings)

IRS No.: 462693615 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations